Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
LETTER
Mengjuan Li, Ning Ding
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#2
LETTER
Lulu Zhang, Lijia Zhou, Yanxia Shi, Xin An
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#3
LETTER
Yiwei Huang, Chunru Xu, Xuesong Li, Xiaoying Li
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#4
LETTER
Rongmei Tang, Qing Chen, Dingbang Wang, Guangbin Chen
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#5
LETTER
Ziqi Shang, Yan Weng, Yong Chen, Qing Zhong
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#6
LETTER
Fei Wang, Liehong Wang, Qingling Qi, Zuchun Wang
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#7
LETTER
Renlong Li, Jiaxiang Gu, Hongjun Liu
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#8
JOURNAL ARTICLE
Jie Huang, Dingwei Xu, Ao Li
TECHNIQUE: Hepatocellular adenoma (HCA) is a benign monoclonal tumour that originates from mature hepatocytes.Liver resection is recommended in case of overt malignant transformation to hepatocellular carcinoma.However, hepatobiliary surgeries are technically challenging in patients with giant HCA (GHCA) owing to the risk of catastrophic intraoperative bleeding and difficulty with its control during laparoscopic treatment. We present a technical note on the utilization of the hepatic vein as anatomical landmarks for laparoscopic removal of giant hepatic glands, without intraoperative ultrasonography and with the aid of an augmented reality navigation system during surgery...
April 20, 2024: Asian Journal of Surgery
#9
LETTER
Jinpeng Xie, Tao Liu, Fan Dai, Jie Lin
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#10
LETTER
Shen Zhongfei, Guo Yanjun
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#11
LETTER
Mingyu Yao, He Zhu, Yong Zhu
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#12
LETTER
Xing Wen, Meng Wang
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#13
LETTER
Qunxing Huang, Rushu Yan, Yi Yang, Tianwen Chen
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#14
LETTER
Xiao-Lei Yin, Shu-Xing Ji, Xiu-Xin Li, Xue-Mei Liang
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#15
LETTER
Xiangmei Kong, Xiaohong Xiang, Zhaoxia Huang, Hongbin Lv
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#16
LETTER
Harald Krentel, Antoine Naem, Gaby Moawad, Rudy Leon De Wilde
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#17
LETTER
Tao Chen, Desong Huang, Xiang Yang, Ping Yang
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#18
LETTER
Ting Lei, Duo Zheng, Xuehan Bi, Chang Liu
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#19
LETTER
Xiaoliang Li, Honghua Yue, Weitao Liang, Zhong Wu
No abstract text is available yet for this article.
April 20, 2024: Asian Journal of Surgery
#20
JOURNAL ARTICLE
Qi Zhang, Xiao-Yan Liang, Ze-Sheng Wang, An Sun, Tin-Bao Cao, Yu-Peng Zhang, Nan Li, Tong-Ying Yi, Kun-Peng Qu
OBJECTIVE: This article is a Meta-analysis aiming to systematically evaluate the difference in efficacy of immune checkpoint inhibitor in patients with non-small cell lung cancer (NSCLC) by age. METHODS: We performed a Meta-analysis of published randomized controlled trials concerning for patients with NSCLC by age. We compared overall survival among three groups (age <65 years, age 65-75 years, age ≥75 years). Hazard ratios (HRs) and 95% confidence intervals (CIs) were collected and pooled...
April 18, 2024: Asian Journal of Surgery
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
